| [1] |
BRANDON-WARNER E, SCHRUM LW, SCHMIDT CM, et al. Rodent models of alcoholic liver disease: of mice and men[J]. Alcohol, 2012, 46( 8): 715- 725. DOI: 10.1016/j.alcohol.2012.08.004.
|
| [2] |
TSUKAMOTO H, MACHIDA K, DYNNYK A, et al.“Second hit” models of alcoholic liver disease[J]. Semin Liver Dis, 2009, 29( 2): 178- 187. DOI: 10.1055/s-0029-1214373.
|
| [3] |
GÄBELE E, DOSTERT K, DORN C, et al. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis[J]. Alcohol Clin Exp Res, 2011, 35( 7): 1361- 1367. DOI: 10.1111/j.1530-0277.2011.01472.x.
|
| [4] |
ZHANG XQ, XU CF, YU CH, et al. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease[J]. World J Gastroenterol, 2014, 20( 7): 1768- 1776. DOI: 10.3748/wjg.v20.i7.1768.
|
| [5] |
HWANG S, REN TY, GAO B. Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake[J]. Clin Mol Hepatol, 2020, 26( 4): 586- 594. DOI: 10.3350/cmh.2020.0100.
|
| [6] |
BISHEHSARI F, MAGNO E, SWANSON G, et al. Alcohol and gut-derived inflammation[J]. Alcohol Res, 2017, 38( 2): 163- 171.
|
| [7] |
KIRPICH IA, MILLER ME, CAVE MC, et al. Alcoholic liver disease: Update on the role of dietary fat[J]. Biomolecules, 2016, 6( 1): 1. DOI: 10.3390/biom6010001.
|
| [8] |
CHEN P, TORRALBA M, TAN J, et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice[J]. Gastroenterology, 2015, 148( 1): 203- 214.e16. DOI: 10.1053/j.gastro.2014.09.014.
|
| [9] |
CHEN YL, PENG HC, WANG XD, et al. Dietary saturated fatty acids reduce hepatic lipid accumulation but induce fibrotic change in alcohol-fed rats[J]. Hepatobiliary Surg Nutr, 2015, 4( 3): 172- 183. DOI: 10.3978/j.issn.2304-3881.2015.01.04.
|
| [10] |
KIRPICH IA, PETROSINO J, AJAMI N, et al. Saturated and unsaturated dietary fats differentially modulate ethanol-induced changes in gut microbiome and metabolome in a mouse model of alcoholic liver disease[J]. Am J Pathol, 2016, 186( 4): 765- 776. DOI: 10.1016/j.ajpath.2015.11.017.
|
| [11] |
SENGUPTA M, ABUIRQEBA S, KAMERIC A, et al. A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis[J]. PLoS One, 2021, 16( 3): e0249316. DOI: 10.1371/journal.pone.0249316.
|
| [12] |
SCHONFELD M, O’NEIL M, VILLAR MT, et al. A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice[J]. Alcohol Clin Exp Res, 2021, 45( 10): 1980- 1993. DOI: 10.1111/acer.14700.
|
| [13] |
PARKER R, KIM SJ, GAO B. Alcohol, adipose tissue and liver disease: Mechanistic links and clinical considerations[J]. Nat Rev Gastroenterol Hepatol, 2018, 15( 1): 50- 59. DOI: 10.1038/nrgastro.2017.116.
|
| [14] |
GAO B, XU MJ, BERTOLA A, et al. Animal models of alcoholic liver disease: Pathogenesis and clinical relevance[J]. Gene Expr, 2017, 17( 3): 173- 186. DOI: 10.3727/105221617X695519.
|
| [15] |
HARRISON-FINDIK DD, KLEIN E, CRIST C, et al. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol[J]. Hepatology, 2007, 46( 6): 1979- 1985. DOI: 10.1002/hep.21895.
|
| [16] |
OHTAKE T, SAITO H, HOSOKI Y, et al. Hepcidin is down-regulated in alcohol loading[J]. Alcoholism Clin Exp Res, 2007, 31( S1): S2- S8. DOI: 10.1111/j.1530-0277.2006.00279.x
|
| [17] |
BRIDLEK, CHEUNGTK, MURPHYT, et al. Hepcidin is down-regulated in alcoholic liver injury: Implications for the pathogenesis of alcoholic liver disease[J]. Alcohol Clin Exp Res, 2006, 30( 1): 106- 112. DOI: 10.1111/j.1530-0277.2006.00002.x.
|
| [18] |
SIKORSKA K, STALKE P, ROMANOWSKI T, et al. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C[J]. Hepatobiliary Pancreat Dis Int, 2013, 12( 4): 377- 384. DOI: 10.1016/s1499-3872(13)60059-4.
|
| [19] |
OLYNYK J, HALL P, REED W, et al. A long-term study of the interaction between iron and alcohol in an animal model of iron overload[J]. J Hepatol, 1995, 22( 6): 671- 676. DOI: 10.1016/0168-8278(95)80222-3.
|
| [20] |
TSUKAMOTO H, HORNE W, KAMIMURA S, et al. Experimental liver cirrhosis induced by alcohol and iron[J]. J Clin Invest, 1995, 96( 1): 620- 630. DOI: 10.1172/JCI118077.
|
| [21] |
NISHIMAKI-MOGAMI T, SUZUKI K, TAKAHASHI A. The role of phosphatidylethanolamine methylation in the secretion of very low density lipoproteins by cultured rat hepatocytes: Rapid inhibition of phosphatidylethanolamine methylation by bezafibrate increases the density of apolipoprotein B48-containing lipoproteins[J]. Biochim Biophys Acta, 1996, 1304( 1): 21- 31. DOI: 10.1016/s0005-2760(96)00100-2.
|
| [22] |
GRUEBELE A, ZAWASKI K, KAPLAN D, et al. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: Effects on signal transduction as demonstrated by altered immediate-early(c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels[J]. Drug Metab Dispos, 1996, 24( 1): 15- 22.
|
| [23] |
SCHOLTEN D, TREBICKA J, LIEDTKE C, et al. The carbon tetrachloride model in mice[J]. Lab Anim, 2015, 49( S1): 4- 11. DOI: 10.1177/002367-7215571192.
|
| [24] |
DOMENICALI M, CARACENI P, GIANNONE F, et al. A novel model of CCl4-induced cirrhosis with ascites in the mouse[J]. J Hepatol, 2009, 51( 6): 991- 999. DOI: 10.1016/j.jhep.2009.09.008.
|
| [25] |
LIEDTKE C, LUEDDE T, SAUERBRUCH T, et al. Experimental liver fibrosis research: Update on animal models, legal issues and translational aspects[J]. Fibrogenesis Tissue Repair, 2013, 6( 1): 19. DOI: 10.1186/1755-1536-6-19.
|
| [26] |
FACCIOLI LAP, DIAS ML, PARANHOS BA, et al. Liver cirrhosis: An overview of experimental models in rodents[J]. Life Sci, 2022, 301: 120615. DOI: 10.1016/j.lfs.2022.120615.
|
| [27] |
BOSMA A, BROUWER A, SEIFERT WF, et al. Synergism between ethanol and carbon tetrachloride in the generation of liver fibrosis[J]. J Pathol, 1988, 156( 1): 15- 21. DOI: 10.1002/path.1711560106.
|
| [28] |
WEBER LWD, BOLL M, STAMPFL A. Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model[J]. Crit Rev Toxicol, 2003, 33( 2): 105- 136. DOI: 10.1080/713611034.
|
| [29] |
COHEN JI, NAGY LE. Pathogenesis of alcoholic liver disease: Interactions between parenchymal and non-parenchymal cells[J]. J Dig Dis, 2011, 12( 1): 3- 9. DOI: 10.1111/j.1751-2980.2010.00468.x.
|
| [30] |
GUHA M, MACKMAN N. LPS induction of gene expression in human monocytes[J]. Cell Signal, 2001, 13( 2): 85- 94. DOI: 10.1016/s0898-6568(00)00149-2.
|
| [31] |
GAO B, BATALLER R. Alcoholic liver disease: Pathogenesis and new therapeutic targets[J]. Gastroenterology, 2011, 141( 5): 1572- 1585. DOI: 10.1053/j.gastro.2011.09.002.
|
| [32] |
ZIMA T, KALOUSOVÁ M. Oxidative stress and signal transduction pathways in alcoholic liver disease[J]. Alcohol Clin Exp Res, 2005, 29( 11 Suppl): 110S- 115S. DOI: 10.1097/01.alc.0000189288.30358.4b.
|
| [33] |
REYES-GORDILLO K, SHAH R, ARELLANES-ROBLEDO J, et al. Akt1 and Akt2 isoforms play distinct roles in regulating the development of inflammation and fibrosis associated with alcoholic liver disease[J]. Cells, 2019, 8( 11): 1337. DOI: 10.3390/cells8111337.
|
| [34] |
PENNINGTON HL, HALL PM, WILCE PA, et al. Ethanol feeding enhances inflammatory cytokine expression in lipopolysaccharide-induced hepatitis[J]. J Gastroenterol Hepatol, 1997, 12( 4): 305- 313. DOI: 10.1111/j.1440-1746.1997.tb00426.x.
|
| [35] |
de la M HALL P, LIEBER CS, DECARLI LM, et al. Models of alcoholic liver disease in rodents: a critical evaluation[J]. Alcohol Clin Exp Res, 2001, 25(5 Suppl ISBRA): 254S- 261S. DOI: 10.1097/00000374-200105-051-00041.
|
| [36] |
XU JS, XU Y, LI YY, et al. Carboxylesterase 1 is regulated by hepatocyte nuclear factor 4α and protects against alcohol- and MCD diet-induced liver injury[J]. Sci Rep, 2016, 6: 24277. DOI: 10.1038/srep24277.
|
| [37] |
XU MJ, CAI Y, WANG H, et al. Fat-specific protein 27/CIDEC promotes development of alcoholic steatohepatitis in mice and humans[J]. Gastroenterology, 2015, 149( 4): 1030- 1041. e 6. DOI: 10.1053/j.gastro.2015.06.009.
|
| [38] |
LU YK, WU DF, WANG XD, et al. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice[J]. Free Radic Biol Med, 2010, 49( 9): 1406- 1416. DOI: 10.1016/j.freeradbiomed.2010.07.026.
|
| [39] |
BUTURA A, NILSSON K, MORGAN K, et al. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model[J]. J Hepatol, 2009, 50( 3): 572- 583. DOI: 10.1016/j.jhep.2008.10.020.
|
| [40] |
Hepatology Branch of the Chinese Medical Association. Guidelines for the prevention and treatment of metabolism-related(non-alcoholic) fatty liver disease(2024 edition)[J]. J Prac Hepatol, 2024, 27( 4): 494- 510. DOI: 10.3760/cma.j.cn501113-20240327-00163.
中华医学会肝病学分会. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J]. 实用肝脏病杂志, 2024, 27( 4): 494- 510. DOI: 10.3760/cma.j.cn501113-20240327-00163.
|
| [41] |
TACKE F, HORN P, WONG VW, et al. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease(MASLD)[J]. J Hepatol, 2024, 81( 3): 492- 542. DOI: 10.1016/j.jhep.2024.04.031.
|